James Investment Research Inc Regenxbio Inc. Transaction History

James Investment Research Inc

  • $853 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 24, 2019
SELL
$42.0 - $59.29 $522,270 - $737,271
-12,435 Closed
0 $0
Q1 2019

Apr 26, 2019
SELL
$40.82 - $62.45 $394,525 - $603,579
-9,665 Reduced 43.73%
12,435 $713,000
Q4 2018

Jan 22, 2019
BUY
$39.11 - $75.15 $864,331 - $1.66 Million
22,100 New
22,100 $927,000

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email